Feds Slam Pharma Execs' Bid To Void Kickback Convictions

By Mike Curley (March 29, 2019, 3:50 PM EDT) -- Federal prosecutors have urged the Second Circuit to reject a bid by two pharmaceutical executives to overturn their convictions in an alleged kickback scheme at Valeant Pharmaceuticals International Inc., saying the "overwhelming evidence" presented at trial undercuts their claims that their only crime was a conflict of interest....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!